Deutsche Bank’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-53,372
Closed -$8.07M 4127
2022
Q3
$8.07M Sell
53,372
-45,560
-46% -$6.89M ﹤0.01% 1027
2022
Q2
$14.4M Sell
98,932
-671,935
-87% -$97.9M 0.01% 872
2022
Q1
$91.4M Sell
770,867
-27,113
-3% -$3.21M 0.04% 398
2021
Q4
$110M Buy
797,980
+60,009
+8% +$8.27M 0.05% 360
2021
Q3
$103M Sell
737,971
-16,323
-2% -$2.27M 0.05% 356
2021
Q2
$73.2M Buy
754,294
+27,614
+4% +$2.68M 0.04% 475
2021
Q1
$49.7M Buy
726,680
+609,527
+520% +$41.7M 0.03% 589
2020
Q4
$10M Sell
117,153
-410,537
-78% -$35.2M 0.01% 1032
2020
Q3
$34.3M Sell
527,690
-82,957
-14% -$5.39M 0.02% 556
2020
Q2
$44.6M Buy
610,647
+44,314
+8% +$3.24M 0.03% 468
2020
Q1
$19.3M Buy
566,333
+73,576
+15% +$2.5M 0.02% 666
2019
Q4
$26.8M Buy
492,757
+399,876
+431% +$21.8M 0.02% 678
2019
Q3
$3.87M Sell
92,881
-53,470
-37% -$2.23M ﹤0.01% 1526
2019
Q2
$6.41M Sell
146,351
-147,244
-50% -$6.45M ﹤0.01% 1646
2019
Q1
$15.1M Buy
293,595
+108,829
+59% +$5.6M 0.01% 1125
2018
Q4
$6.83M Sell
184,766
-80,244
-30% -$2.97M ﹤0.01% 1542
2018
Q3
$9.95M Buy
265,010
+64,725
+32% +$2.43M 0.01% 1636
2018
Q2
$7.92M Buy
200,285
+138,507
+224% +$5.47M ﹤0.01% 1935
2018
Q1
$1.59M Buy
61,778
+38,198
+162% +$984K ﹤0.01% 2996
2017
Q4
$635K Buy
23,580
+5,248
+29% +$141K ﹤0.01% 3406
2017
Q3
$683K Buy
18,332
+5,201
+40% +$194K ﹤0.01% 3190
2017
Q2
$326K Buy
+13,131
New +$326K ﹤0.01% 3567